Ruth Cousineau
Beverly Hills, CANPI 1386699726
Payments from drug & device makers
Across 185 payments — averaging $19.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Daiichi Sankyo Inc.$358
- Pfizer$244
- Coopersurgical, Inc.$196
- Myovant Sciences Inc.$158
- Astellas Pharma US Inc$156
- plus $799 from 25 others
What the payments were for
- Food & beverage$3,49298%
- Education$572%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 84 | $1,639 |
| Daiichi Sankyo Inc. | 14 | $358 |
| Pfizer | 14 | $244 |
| Coopersurgical, Inc. | 10 | $196 |
| Myovant Sciences Inc. | 10 | $158 |
| Astellas Pharma US Inc | 7 | $156 |
| Therapeuticsmd, Inc. | 9 | $130 |
| Mayne Pharma Commercial LLC | 4 | $94 |
| Hologic Sales And Service, LLC | 3 | $57 |
| Bayer | 2 | $48 |
| Vertical Pharmaceuticals, LLC | 3 | $47 |
| AMAG Pharmaceuticals, Inc. | 2 | $41 |
| Agile Therapeutics, Inc. | 2 | $36 |
| Sumitomo Pharma America, Inc. | 2 | $33 |
| Lupin Inc. | 2 | $29 |
| Evofem Biosciences, Inc. | 2 | $28 |
| Shield Therapeutics Inc | 1 | $26 |
| 180 Medical, Inc. | 1 | $26 |
| Duchesnay USA Incorporated | 1 | $22 |
| Scynexis, Inc. | 1 | $20 |
| Exact Sciences | 1 | $19 |
| Medicem Inc. | 1 | $19 |
| BD | 1 | $18 |
| Avion Pharmaceuticals | 1 | $17 |
| Avanos Medical | 1 | $17 |
| Minerva Surgical, Inc | 1 | $16 |
| Mycovia Pharmaceuticals, Inc. | 1 | $13 |
| Endo Pharmaceuticals Inc. | 1 | $13 |
| AstraZeneca | 1 | $11 |
| Covidien LP | 1 | $11 |
| Channel Medsystems, Inc. | 1 | $9 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Orilissa$125
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 36 | $4,076 |
Paid to pharmacies, not to this prescriber.
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.